Further development of the ImmuPHAGE™ model has been the focus of Amjad’s work during his time at ImmuONE. This model is composed of alveolar macrophage-like cells which are assembled in vitro in well plates and closely mimic the form and function of their human counterparts found within the alveoli of the deep lung.
At ImmuONE, we believe in fostering the growth and development of young talents in the field of biotechnology. Our commitment to nurturing bright minds extends beyond cutting-edge research; it’s about shaping the future of healthcare by empowering the leaders of tomorrow. We offer secondary school students valuable experiences through initiatives like the Nuffield Research Placements, which allow young people to find out what it’s like to work in a real biotech company and engage in a meaningful scientific project. Today, we’d like to introduce two of our promising students, Beverley Twum and Riqza Shad, who recently embarked on a two-week placement journey with us. Nilab Hydare, pre-clinical scientist at ImmuONE, skillfully led the project and served as a supportive mentor and supervisor to the students. Their guidance and expertise were instrumental in the success of this endeavor. They’ve agreed to share their insights and experiences, offering a glimpse into what they’ve learned at ImmuONE.
The annual AIT conference, held in Gothenburg, Sweden from May 2nd to 5th, provided ImmuONE with a valuable platform
As a first-time visitor to the Society of Toxicology (SOT) Annual Meeting and the US for that matter, I was unsure of what to expect when visiting Nashville last week for the 23rd SOT symposium.
When I first stepped onto the University of Hertfordshire campus, ready to embark on my PhD in immunology, I didn’t know where the future would take me.
